Search Results - Takumi Tsujia

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Telmisartan Exacerbates Cisplatin-Induced Nephrotoxicity in a Mouse Model

    Telmisartan Exacerbates Cisplatin-Induced Nephrotoxicity in a Mouse Model by Hosoda, Atsuki, Matsumoto, Yoshio, Toriyama, Yuuki, Tsuji, Takumi, Yoshida, Yuya, Masamichi, Shuji, Kohno, Takeyuki

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Characterization of an Expanded IL-10-Producing-Suppressive T Cell Population Associated with Immune Tolerance

    Characterization of an Expanded IL-10-Producing-Suppressive T Cell Population Associated with Immune Tolerance by Yuya Yoshidaa, Norihisa Mikamib, Yusuke Nakanishia, Maya Saimotoa, Arata Nagaikea, Haruka Shimonoa, Shohei Nakanoa, Takumi Tsujia, Takeyuki Kohnoa

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC/Nga mice

    Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC/Nga mice by Tsuji, Takumi, Okuno, Satoshi, Kuroda, Ayano, Hamazaki, Junya, Chikami, Takuma, Sakurai, Sakura, Yoshida, Yuya, Banno, Rie, Fujita, Tetsuro, Kohno, Takeyuki

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Functional Mechanism (s) of the Inhibition of Disease Progression by Combination Treatment with Fingolimod Plus Pathogenic Antigen in a Glucose-6-phosphate Isomerase Peptide-Induced Arthritis Mouse Model

    Functional Mechanism (s) of the Inhibition of Disease Progression by Combination Treatment with Fingolimod Plus Pathogenic Antigen in a Glucose-6-phosphate Isomerase Peptide-Induce... by Yuya Yoshidaa, Norihisa Mikamib, Yuki Matsushimaa, Fumiya Otania, Mai Miyawakia, Miku Takatsujib, Rie Bannoa, Takumi Tsujia, Tetsuro Fujitac, Kazutake Tsujikawab, Takeyuki Kohnoa, c

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Efficacy of Combination Treatment with Fingolimod (FTY720) Plus Pathogenic Autoantigen in a Glucose-6-phosphate Isomerase Peptide (GPI325-33g)-Induced Arthritis Mouse Model

    Efficacy of Combination Treatment with Fingolimod (FTY720) Plus Pathogenic Autoantigen in a Glucose-6-phosphate Isomerase Peptide (GPI325-33g)-Induced Arthritis Mouse Model by Yuya Yoshidaa, Takumi Tsujia, Sayaka Watanabea, Ayane Matsushimaa, Yuki Matsushimaa, Rie Bannob, Tetsuro Fujitac, Takeyuki Kohnoa, c

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Relapse of Experimental Autoimmune Encephalomyelitis after Discontinuation of FTY720 (Fingolimod) Treatment, but Not after Combination of FTY720 and Pathogenic Autoantigen

    Relapse of Experimental Autoimmune Encephalomyelitis after Discontinuation of FTY720 (Fingolimod) Treatment, but Not after Combination of FTY720 and Pathogenic Autoantigen by Yuya YOSHIDAa, Takumi TSUJIa, Tetsuro FUJITAb, Takeyuki KOHNOa, b

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    A Novel Immunomodulator, FTY720, Prevents Development of Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice

    A Novel Immunomodulator, FTY720, Prevents Development of Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice by Takeyuki KOHNOa, Takumi TSUJIa, Kaori HIRAYAMAa, Rumi IWATSUKIa, Michitaka HIROSEa, Kazuhito WATABEa, Hiroaki YOSHIKAWAb, Tomoko KOHNOc, Akiko MATSUMOTOc, Tetsuro FUJITAc, Masatoshi HAYASHId

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: